However, in vivo experiments with these compounds had limitations, namely the rapid metabolism of 10074-G5 to inactive metabolites resulted in tumor concentrations of 10074-G5 insufficient to inhibit c-MYC/MAX dimerization [174]. This evidence concerns the gene MYC and neoplasm.